Active, not recruitingNCT07538908

Superselective Renal Artery Embolization for Renal Angiomyolipoma

Studying Perivascular epithelioid cell neoplasm

Last synced from ClinicalTrials.gov May 17, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Botkin Hospital
Principal Investigator: Vigen Malkhasyan, Doctor of Medical Sciences
Head of the department
Intervention: Selective endovascular embolization of kidney artery(procedure)
Enrollment: 50 target
Eligibility: 18 years · All sexes
Timeline: 2026 – 2027

Study locations (1)

Botkin City Hospital, Moscow, Russia

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07538908 on ClinicalTrials.gov

← Back to all trials